Not Yet RecruitingNot Applicable

Feasibility of Using NeuraSignal Transcranial Doppler Robot

United States20 participantsStarted 2026-06-15

Plain-language summary

The purpose of this study is to determine the feasibility of using the NeuraSignal transcranial doppler robot in a neuro ICU setting to measure cerebral blood flow correlated with arterial blood pressure to generate individualized cerebral autoregulatory curves

Who can participate

Age range18 Years – 89 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18-89 * Patients admitted to the Neuro ICU for blood pressure management (MAP management) after spinal surgery Exclusion Criteria: * Patients under 18 years (or bodyweight \<50kg if age unknown), * prisoners * pregnant women, * non-English speaking, * patients enrolled in concurrent * ongoing interventional trial * students of UAB * employees of UAB * targeting specific populations * patients with previously diagnosed brain pathology * patients with open wounds over temporal bones precluding transcranial doppler

What they're measuring

Primary outcome

Timeframe: one year

Trial details

NCT IDNCT06565442

SponsorUniversity of Alabama at Birmingham

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-12-14

Contact for this trial

Shanna Graves

205-975-2845 shannagraves@uabmc.edu

View on ClinicalTrials.gov More Cerebral Autoregulation trials